Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.
31-Dec-08
3,022.20
268.00
32.10¢
49.4
n/a
n/a 9.91¢
0.6%
31-Dec-09
3,007.70
642.30
119.00¢
15.9
0.1
+271% 11.40¢
0.6%
31-Dec-10
3,471.10
770.70
107.70¢
22.4
n/a
-10% 13.10¢
0.5%
31-Dec-11
4,263.40
1,092.60
156.90¢
22.4
0.5
+46% 15.07¢
0.4%
31-Dec-12
4,681.20
912.40
134.20¢
22.0
n/a
-14% 17.33¢
0.6%
a. Based on UK GAAP presentation of accounts - includes discontinued activities
31-Dec-13
3,202.64 949.39
145.28p
14.4
0.2
+70% 11.99p
0.6%
31-Dec-14
3,440.28 1,101.85
164.89p
12.7
0.9
+14% 14.97p
0.7%
No deals were found in the last 28 days.
Strong Buy
20
Buy
2
Neutral
7
Sell
0
Strong Sell
0
Total
29
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.
2nd Interim
Interim
Ex-Div
06-Mar-13
05-Sep-12
Paid
09-Apr-13
04-Oct-12
Amount
14.60¢
2.73¢
16:42
35,845 @ 2,085.81p
16:38
16,200 @ 2,085.95p
14:18
100,000 @ 2,086.00p
16:35
311,972 @ 2,086.00p
16:29
9 @ 2,089.00p
Chair
Matthew Emmens
CFO
Graham Hetherington
CEO
Flemming Ornskov
-1.00p Market Cap: £11,550m